Dror Ortho-Design, Inc.

Dror Ortho-Design, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the nine months ended September 30, 2025 (the “Form 10-Q”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q. The Company currently anticipates that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date

Dror Ortho-Design, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (the “Form 10-Q”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q. The Company currently anticipates that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date

Dror Ortho-Design, Inc. (the “Company”) plans to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) as soon as practicable and within the five calendar day period provided by Rule 12b-25 for delayed filings. The delay is due primarily to the recent business combination and related transactions described below. As previously reported, on August 14, 2023, pursuant to that certain Share Exchange Agreement, dated as of July 5, 2023 (as amended, the “Exchange Agreement”) by and among the Company, Dror Ortho-Design Ltd., a company incorporated under the laws of the State of Israel (“Private Dror”) and all shareholders of Private Dror, the shareholders of Private Dror transferred all of their ordinary shares in Private Dror to the Company in exchange for newly issued shares of Company’s Series A Convertible Preferred Stock, par value $0.0001 per share (the “Preferred Stock”) and shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock,” and the transaction, the “Share Exchange”). As a result of the Share Exchange, Private Dror became a wholly owned subsidiary of the Company. In connection with the Share Exchange, pursuant to that certain Securities Purchase Agreement, dated as of August 14, 2023 (the “Securities Purchase Agreement”), the Company sold an aggregate of (1) 204,545,448 shares of Common Stock and 2,704,545 shares of Preferred Stock at an effective purchase price of $0.011 per share of Common Stock either sold or underlying each share of Preferred Stock and (2) five-year warrants to purchase an aggregate of 474,999,993 shares of Common Stock at an exercise price of $0.033 per share (“Warrants”) in a private placement to certain investors (the “Private Placement”)

The Form 10-Q for the period ended March 31, 2021 for Novint Technologies, Inc. could not be filed within the prescribed period because the Company was unable to complete certain financial information critical to filing a timely and accurate report. Such inability could not have been eliminated by the Registrant without unreasonable effort or expense